title: Application of Proteomics in Acute Graft-Versus-Host Disease Management: An Integrative Review and Nursing Implications.
abstract: BACKGROUND
  After allogeneic hematopoietic stem cell transplantation, one of the major barriers to clinical management of acute graft-versus-host disease (aGVHD) is a lack of reliable and validated noninvasive tests for diagnosis and prognosis. Proteomic studies have indicated a strong correlation between the level of certain body fluid proteins and clinical outcomes after aGVHD. Specific proteins have been identified that could be robust biomarkers for overall prognosis or for differential diagnosis of target organs in aGVHD.
  
  
  OBJECTIVE
  The authors aimed to evaluate the literature related to proteomic biomarkers that are indicated in the occurrence, severity, and management of aGVHD.
  
  
  METHODS
  PubMed and CINAHL® databases were searched for articles published from January 2004 to June 2014. Eight articles matching the inclusion criteria were identified, and the findings of these articles were summarized and their clinical implications noted.
  
  
  RESULTS
  Proteomics appears to be a promising tool to assist oncology nurses and nurse practitioners with patient education, develop personalized plans of care to reduce morbidity, initiate communication regarding end-of-life decisions, and improve overall nursing management of the population of patients with aGVHD.
authors.affiliation: University of Texas MD Anderson Cancer Center.
authors.forename: Nilesh
authors.initials: N
authors.lastname: Kalariya
authors.affiliation: University of Texas MD Anderson Cancer Center.
authors.forename: Kelly
authors.initials: K
authors.lastname: Brassil
mesh_terms: D000208:Acute Disease; D006086:Graft vs Host Disease / Q000451:nursing / Q000628:therapy*; D006801:Humans; D040901:Proteomics
keywords: aGVHD; allogeneic HSCT; biomarker; body fluids; protein; proteomics